GlassScriptPhysician profile
Randy A Pierce
NPI 1578981932
$826.86
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.61 · 2023: $96.63 · 2024: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Education: $56.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.25 |
| Education | $56.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $142.15 | 2024 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $110.47 | 2024 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $104.74 | 2024 | |
| Hikma Pharmaceuticals USA | $74.18 | 2023 | Kloxxado |
| Novo Nordisk INC | $52.43 | 2024 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.03 | 2024 | Jardiance |
| Indivior INC. | $48.18 | 2019-2024 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $44.88 | 2024 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $40.57 | 2024 | Rexulti |
| Esperion Therapeutics, INC. | $23.49 | 2024 | Nexletol |
| Boston Scientific Corporation | $22.45 | 2023 | Varithena Administration Pack |
| Takeda Pharmaceuticals U.S.A., INC. | $20.30 | 2024 | Trintellix |
| Merck Sharp & Dohme LLC | $19.92 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Corcept Therapeutics | $19.63 | 2024 | Korlym |
| Radius Health, INC. | $18.47 | 2024 | Tymlos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.24 | 2024 | |
| Glaxosmithkline, LLC. | $15.73 | 2024 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.